Peter M. Hecht
Founder of Ironwood Pharmaceuticals, Inc. and Cyclerion Therapeutics, Inc., Peter M. Hecht is Chief Executive Officer & Director at Cyclerion Therapeutics, Inc. He is also on the board of Kallyope, Inc. and Mythic Therapeutics, Inc.
He previously was Chief Executive Officer & Director at Ironwood Pharmaceuticals, Inc.
Dr. Hecht received a graduate degree and an undergraduate degree from Stanford University and a doctorate from the University of California, Berkeley.
Transactions
Date
Transaction
Value
| 06/03/2021 | 823,170 | Acquisition at $3.28 per share. | 2,699,997 |
| 05/06/2021 | 302,000 | Acquisition at $2.43 per share. | 733,860 |
| 05/05/2021 | 398,001 | Acquisition at $2.53 per share. | 1,006,942 |
| 05/04/2021 | 300,000 | Acquisition at $2.29 per share. | 687,000 |
| 07/10/2019 | 2,000 | Derivative/Non-derivative trans. at $6.04 per share. | 12,080 |
| 04/01/2019 | 485 | Award at $0 per share. | 0 |
| 04/01/2019 | 485 | Award at $0 per share. | 0 |
| 04/01/2019 | 485 | Award at $0 per share. | 0 |
| 04/01/2019 | 221,736 | Award at $0 per share. | 0 |
